Related Experiment Video
Updated: Apr 14, 2026
06:48
Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
22.4K
What Is Next for Retinal Gene Therapy?
1Ocular Genomics Institute, Grousbeck Gene Therapy Center, Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts 02114.
Cold Spring Harbor Perspectives in Medicine
|April 17, 2015
Summary
Gene therapy offers a promising new treatment for inherited retinal diseases, showing feasibility, safety, and effectiveness. This approach may become a standard part of eye care, despite current limitations.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Inherited retinal degenerations are a leading cause of blindness with limited treatment options.
- Gene therapy is emerging as a viable therapeutic strategy for ocular diseases.
Purpose of the Study:
- To review the current state and future potential of gene therapy for retinal blinding disorders.
- To discuss the technical, clinical, and economic challenges hindering gene therapy's widespread adoption.
- To explore the integration of gene therapy into routine ophthalmic clinical practice.
Main Methods:
- Review of early-stage clinical trial data for gene therapy in inherited retinal degenerations.
- Analysis of existing literature on the feasibility, safety, and efficacy of ocular gene therapy.
- Discussion of current and future challenges in the application and development of gene therapy.
Main Results:
- Early clinical trials demonstrate hopeful results for gene therapy in treating inherited retinal diseases.
- Gene therapy has shown feasibility, safety, and effectiveness, potentially offering durable effects after a single administration.
- Despite successes, technical, clinical, and economic hurdles remain.
Conclusions:
- Gene therapy holds significant promise for treating retinal blinding disorders and may become a standard ophthalmic treatment.
- Addressing current limitations is crucial for realizing the full potential of gene therapy in eye care.
- Further development is needed to integrate gene therapy seamlessly into clinical practice.
Related Concept Videos
00:59Gene Therapy
28.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.2K
01:20The Retinoblastoma Gene
5.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
01:20The Retinoblastoma Gene
2.9K
2.9K